Antibody-Drug Conjugates as Radiopharmaceutical Theranostics for Cancer
This grant opportunity supports the development of an innovative treatment approach using antibody-drug conjugates (ADCs) combined with radionuclides for cancer therapy. The project aims to overcome the limitations of ADCs, such as cancer resistance and ineffective drug delivery, by adding radionuclides that enable diagnostic imaging and enhance therapeutic effects. The use of diagnostic radio…
Fast-Track proposals will be accepted.\nDirect-to-Phase II proposals will be accepted.\nNumber of anticipated awards: 3-5\nBudget (total costs, per award):\nPhase I: up to $400,000 for up to 12 months\nPhase II: up to $2,250,000 for up to 2 years\nPROPOSALS THAT EXCEED THE BUDGET OR PROJECT DURA…
Funding Source
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers